The use of alefacept in the treatment of psoriasis.
Langley
Richard
R
Mediprobe Research Inc., London, Ontario, Canada.
Gupta
Aditya K
AK
Poulin
Yves
Y
Guenther
Lyn
L
Barber
Kirk
K
Gulliver
Wayne
W
Lynde
Charles
C
D000077944:Alefacept; D001688:Biological Products / Q000627:therapeutic use; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects; D011565:Psoriasis / Q000188:drug therapy*; D011993:Recombinant Fusion Proteins / Q000494:pharmacology / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000502:physiology; D016896:Treatment Outcome
D001688:Biological Products; D011993:Recombinant Fusion Proteins; D000077944:Alefacept